Systematic Review With Meta-Analysis: The Efficacy and Safety of CT-P13, a Biosimilar of Anti-Tumour Necrosis Factor-Α Agent (Infliximab), in Inflammatory Bowel Diseases

Alimentary Pharmacology and Therapeutics - United Kingdom

doi 10.1111/apt.13990